Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. - Wikidata - awgldk - TriplyDB

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

http://www.wikidata.org/entity/Q36342987

about

Facioscapulohumeral dystrophy: the path to consensus on pathophysiology SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.Human skeletal muscle xenograft as a new preclinical model for muscle disorders DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle Next-generation sequencing analysis of miRNA expression in control and FSHD myogenesis.DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.Effective classification and gene expression profiling for the Facioscapulohumeral Muscular Dystrophy Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases.Evaluation of gene expression classification studies: factors associated with classification performance Clinical immunology and multiplex biomarkers of human tuberculosis Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.Proteomics analyses of subcutaneous adipocytes reveal novel abnormalities in human insulin resistance.Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles.Next-generation qPCR for the high-throughput measurement of gene expression in multiple leukocyte subsets.PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.Role of adipocyte mitochondria in inflammation, lipemia and insulin sensitivity in humans: effects of pioglitazone treatment.The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts.Facioscapulohumeral Muscular Dystrophy.Tissue-specific activities of the Fat1 cadherin cooperate to control neuromuscular morphogenesis.

P2860

Q21195884-68FBE26D-A12F-4F31-9DC1-E3020267130D Q30009101-8F151B16-2948-4FC3-90F5-97A2D5033E02 Q30394383-6B3FEF0C-AF12-4D94-83BC-5D6100ED39D3 Q33602618-D2B39661-221A-4530-89D5-CBE0D6DD87FA Q33649287-B4899D67-F599-4264-9912-FCB1464CFC78 Q34211798-42AE4DB9-C046-401A-9894-1FEFE0F105FC Q34294130-18A9C8FB-5DDD-495E-9A4A-64B9BCE68440 Q34746238-B78617AD-5855-4E1A-BC6F-9FE114146435 Q35040061-3661B3A1-52EC-4A5E-9946-EC3B66390ABC Q35069968-CFA996CC-B1F8-4C93-A083-69CFD43D154E Q35094699-89B5325D-DFF1-4E24-B8C9-1C1947BBA04E Q35128103-BCD0B7C8-3212-496A-8692-10C9A8E1AF59 Q35158226-3E8BC7FF-7BF9-4AE8-8A1E-6C7E362064A9 Q35245278-C4D15BF9-09A0-4313-983C-E24BC7D6F179 Q35518696-3ED5B742-FC81-409B-8FD6-8CD73DB4380C Q35608609-844644B1-B549-4458-92BB-95193D2E6750 Q35811204-AB635796-1DFE-4DE5-9D04-6E1489CADCBF Q36028441-42F943FE-EB5B-4BBB-8712-DC37BBC62129 Q36305436-5D39FDE0-484A-4CF8-92D9-388313A7970C Q37051235-AE61AEDB-537A-48CB-8CD1-F8FFFA5B4357 Q37256163-44CA1DB6-3328-419D-9CFD-5DCE3A505066 Q37413081-1143338E-96FE-4B4B-A55E-E15422138026 Q37590285-24892322-0010-435A-92E7-3D543681A8A6 Q37595289-BBC2E5D0-6B5F-479D-AC86-0C1522BA8F0E Q38699065-5404F04D-323C-4DEE-BC95-BA3C678DA71D Q38768975-4EDB3E30-59C4-42FD-91C3-3E0EB50E7B74 Q43704392-DDD25F1F-7433-4525-B8AE-D697E098A771 Q47146410-0847B2B2-DE3B-4338-9DD9-90E483435AE3 Q47583449-2AF73FC2-299C-4A87-B4BE-CC7A4A9530C8 Q47764909-C167BD14-FE65-4A27-BDEB-33FD0595F9EF Q48766406-1ED6BEC4-5498-4D54-9739-B85FE3410965 Q52506936-9502CD3C-C1D4-4175-B7A9-0FB073C33E3B Q55094954-0994C409-17F2-4960-B9F8-5391E6691088

P2860

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

http://www.wikidata.org/entity/Q36342987

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Transcriptional profiling in f ...... identify candidate biomarkers.

@ast

Transcriptional profiling in f ...... identify candidate biomarkers.

@en

type

label

Transcriptional profiling in f ...... identify candidate biomarkers.

@ast

Transcriptional profiling in f ...... identify candidate biomarkers.

@en

prefLabel

Transcriptional profiling in f ...... identify candidate biomarkers.

@ast

Transcriptional profiling in f ...... identify candidate biomarkers.

@en

P1433

Q36342987-BE88895A-B0AA-4F15-B9CF-BF2B6279B55F

P1476

Q36342987-0AA80F51-6235-44FB-9C0D-4BF2AC99572C

P2093

Q36342987-0509C178-0DD5-49D6-A23F-45AD0C60FB09

Q36342987-2B682103-63B4-4BF9-8696-9FAE90100A40

Q36342987-733A4E0E-D495-4100-8089-F9A1D118C8CE

Q36342987-B513B853-2269-4458-9FC1-47094AA55567

Q36342987-B8816106-D379-4C56-A8D6-67CFF14BF2B6

Q36342987-E3F1CF19-3104-4F32-A746-7C82C073DB54

P2860

Q36342987-04D727B0-C882-4B9F-8967-CF91D66DE35B

Q36342987-06280620-70B0-4412-93D1-8116835AEA5D

Q36342987-09E98D90-0D57-4D0D-97B5-A39F19C34CB8

Q36342987-131A1A85-B02D-4FEC-8AEC-5CBA4D0D21B1

Q36342987-1D434CDB-1B1B-43FA-8E22-9C41D48C2AE2

Q36342987-3372D3BB-C572-40E7-89FB-C20721E0424A

Q36342987-3501A91A-B170-4061-B87F-B2439EFA6E96

Q36342987-4948149C-2E0D-4DAD-8F4B-A25F4D8EEFAF

Q36342987-4E7332D9-5357-4E70-86B5-20EA4357A426

Q36342987-573CBC8F-ABE5-4697-9741-D81961F2BD43

P304

Q36342987-C7C63D5B-306D-4E11-BFE1-854875DFB09F

P31

Q36342987-88DC0794-03C3-44CD-B495-8E9E15FB519B

P356

Q36342987-5B32D5C7-7A9C-4F8F-ABD8-064E5994C253

P407

Q36342987-0776713A-BBF1-4AF1-BD94-91C6F5288CAF

P433

Q36342987-BE987FFD-5992-4633-91E0-0793B1531B0B

P478

Q36342987-6DC8F76E-9364-48BE-86D4-8F47C8A8F2FE

P50

Q36342987-FF518815-D70C-4ACE-87D0-E4DBBEF0B845

P577

Q36342987-D7EBEEC6-4209-4B96-8203-72C1A7D4C026

P5875

Q36342987-EA6B2E05-8A59-4A19-8780-6927C092933A

P698

Q36342987-2FFCAC27-6720-499B-AB44-C7FAD3720FC3

P921

Q36342987-66ECAF9A-284B-44BB-BEAA-88635EB5ED1B

Q36342987-8575A974-FF6E-4F45-B15B-7E1ADDA5C72B

P932

Q36342987-53C1E9CC-E0E2-408A-A43B-655063F05279

P356

PNAS.1209508109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Transcriptional profiling in f ...... identify candidate biomarkers

@en

P2093

Charles P Emerson

http://www.w3.org/2001/XMLSchema#string

Fedik Rahimov

http://www.w3.org/2001/XMLSchema#string

Genila M Bibat

http://www.w3.org/2001/XMLSchema#string

Kathryn R Wagner

http://www.w3.org/2001/XMLSchema#string

Louis M Kunkel

http://www.w3.org/2001/XMLSchema#string

Oliver D King

http://www.w3.org/2001/XMLSchema#string

P2860

Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene

DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1

Trismus-pseudocamptodactyly syndrome is caused by recurrent mutation of MYH8

The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein

IDI2, a second isopentenyl diphosphate isomerase in mammals

Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

Summaries of Affymetrix GeneChip probe level data

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

Isopentenyl diphosphate isomerase: a core enzyme in isoprenoid biosynthesis. A review of its biochemistry and function

P304

16234-16239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1209508109

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230871913

http://www.w3.org/2001/XMLSchema#string

P698

22988124

http://www.w3.org/2001/XMLSchema#string

P921

facioscapulohumeral muscular dystrophy

P932

3479603

http://www.w3.org/2001/XMLSchema#string